home / stock / tlgt / tlgt news

TLGT News and Press, Teligent Inc. From 04/08/20

Stock Information
Company Name: Teligent Inc.
Stock Symbol: TLGT
Market: NASDAQ
Website: teligent.com
Menu
TLGT TLGT Quote TLGT Short TLGT News TLGT Articles TLGT Message Board
Get TLGT Alerts

News, Short Squeeze, Breakout and More Instantly...
TLGT - Teligent EPS misses by $0.15, misses on revenue

Teligent (NASDAQ: TLGT ): Q4 Non-GAAP EPS of -$0.17 misses by $0.15 ; GAAP EPS of -$0.10 misses by $0.01 . More news on: Teligent, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

TLGT - TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2019 RESULTS & AMENDMENTS TO EXISTING SECURED CREDIT FACILITIES

BUENA, N.J., April 08, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth quarter and year ended December 31, 2019. Fourth Quarter 2019 Highlights Net Revenues for ...

TLGT - Teligent, Inc. to Hold Conference Call for Fourth Quarter and 2019 Full Year Financial Results on Wednesday April 8, 2020

BUENA, N.J., April 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00 a.m. ET on Wednesday, April 8, 2020 to discuss the 4 th quarter and 2019 full year financial result...

TLGT - Teligent, Inc. Announces Transition in Leadership

BUENA, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced a transition in leadership. Teligent has announced that Jason Grenfell-Gard...
TLGT - Teligent, Inc. Announces FDA Request for Further Data on Complex Drug

BUENA, N.J., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its development partner has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its abbreviat...

TLGT - Teligent, Inc. to Present at Jefferies Global Healthcare Conference in London on Wednesday November 20, 2019

BUENA, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies Global Healthcare Conference. The Conference is taking place November 20-21, 2019 in London, UK. Jason Grenfell-Gardn...

TLGT - Teligent, Inc. (TLGT) CEO Jason Grenfell-Gardner on Q3 2019 Results - Earnings Call Transcript

Teligent, Inc. (TLGT) Q3 2019 Earnings Conference Call November 4, 2019, 16:30 PM ET Company Participants Jason Grenfell-Gardner - President and CEO Damian Finio - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Scott Henry - ROTH Capital Elliot Wilbur...
TLGT - Teligent EPS misses by $0.02, misses on revenue

Teligent (NASDAQ: TLGT ): Q3 Non-GAAP EPS of -$0.04 misses by $0.02 ; GAAP EPS of -$0.13 misses by $0.04 . More news on: Teligent, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

TLGT - Teligent, Inc. Announces Third Quarter 2019 Results

BUENA, N.J., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter ended September 30, 2019. Third Quarter 2019 Highlights Net revenues of $18.5 millio...

TLGT - Teligent, Inc. to Hold Conference Call for Third Quarter 2019 Results on Monday November 4th, 2019

BUENA, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 4:30pm ET on Monday November 4 th , 2019 to discuss the 3 rd quarter 2019 financial results and business ...
Previous 10 Next 10